Post-marketing safety of pimavanserin: a real-world pharmacovigilance study based on the FDA adverse event reporting system (FAERS)
用户dxJFKQy3yDZo
1个月前
108
10
已完结
1. 系统已在2026-08-31 18:43:22对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1080/14740338.2025.2460444
文献链接: https://www.tandfonline.com/doi/full/10.1080/14740338.2025.2460444
其他信息:
出版社: Informa UK Limited
作者: Dong Liu; Xueni Zhang; Haiyan Xu
全文下载地址: https://www.tandfonline.com/doi/pdf/10.1080/14740338.2025.2460444
